risperdal 1 mg smeltetabletter
janssen-cilag a/s - risperidon - smeltetabletter - 1 mg
risperdal 2 mg smeltetabletter
janssen-cilag a/s - risperidon - smeltetabletter - 2 mg
risperdal consta 37,5 mg depotinjektionsvæske, pulver og solvens til suspension
janssen-cilag a/s - risperidon - depotinjektionsvæske, pulver og solvens til suspension - 37,5 mg
risperdal consta 50 mg depotinjektionsvæske, pulver og solvens til suspension
janssen-cilag a/s - risperidon - depotinjektionsvæske, pulver og solvens til suspension - 50 mg
sibelium 10 mg filmovertrukne tabletter
janssen-cilag a/s - flunarizinhydrochlorid - filmovertrukne tabletter - 10 mg
topimax 100 mg filmovertrukne tabletter
janssen-cilag a/s - topiramat - filmovertrukne tabletter - 100 mg
topimax 200 mg filmovertrukne tabletter
janssen-cilag a/s - topiramat - filmovertrukne tabletter - 200 mg
topimax 50 mg filmovertrukne tabletter
janssen-cilag a/s - topiramat - filmovertrukne tabletter - 50 mg
topimax 25 mg kapsler, hårde
janssen-cilag a/s - topiramat - kapsler, hårde - 25 mg
invokana
janssen-cilag international nv - canagliflozin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5.